16-55491248-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_004530.6(MMP2):​c.1181-553C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.271 in 151,864 control chromosomes in the GnomAD database, including 6,783 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.27 ( 6783 hom., cov: 31)

Consequence

MMP2
NM_004530.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0630

Publications

5 publications found
Variant links:
Genes affected
MMP2 (HGNC:7166): (matrix metallopeptidase 2) This gene is a member of the matrix metalloproteinase (MMP) gene family, that are zinc-dependent enzymes capable of cleaving components of the extracellular matrix and molecules involved in signal transduction. The protein encoded by this gene is a gelatinase A, type IV collagenase, that contains three fibronectin type II repeats in its catalytic site that allow binding of denatured type IV and V collagen and elastin. Unlike most MMP family members, activation of this protein can occur on the cell membrane. This enzyme can be activated extracellularly by proteases, or, intracellulary by its S-glutathiolation with no requirement for proteolytical removal of the pro-domain. This protein is thought to be involved in multiple pathways including roles in the nervous system, endometrial menstrual breakdown, regulation of vascularization, and metastasis. Mutations in this gene have been associated with Winchester syndrome and Nodulosis-Arthropathy-Osteolysis (NAO) syndrome. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2014]
MMP2 Gene-Disease associations (from GenCC):
  • multicentric osteolysis, nodulosis, and arthropathy
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • multicentric osteolysis-nodulosis-arthropathy spectrum
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.365 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004530.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MMP2
NM_004530.6
MANE Select
c.1181-553C>T
intron
N/ANP_004521.1P08253-1
MMP2
NM_001127891.3
c.1031-553C>T
intron
N/ANP_001121363.1P08253-3
MMP2
NM_001302508.1
c.953-553C>T
intron
N/ANP_001289437.1P08253-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MMP2
ENST00000219070.9
TSL:1 MANE Select
c.1181-553C>T
intron
N/AENSP00000219070.4P08253-1
MMP2
ENST00000437642.6
TSL:1
c.1031-553C>T
intron
N/AENSP00000394237.2P08253-3
MMP2
ENST00000570308.5
TSL:1
c.953-553C>T
intron
N/AENSP00000461421.1P08253-2

Frequencies

GnomAD3 genomes
AF:
0.272
AC:
41222
AN:
151746
Hom.:
6780
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0793
Gnomad AMI
AF:
0.510
Gnomad AMR
AF:
0.364
Gnomad ASJ
AF:
0.263
Gnomad EAS
AF:
0.145
Gnomad SAS
AF:
0.250
Gnomad FIN
AF:
0.320
Gnomad MID
AF:
0.285
Gnomad NFE
AF:
0.369
Gnomad OTH
AF:
0.282
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.271
AC:
41216
AN:
151864
Hom.:
6783
Cov.:
31
AF XY:
0.269
AC XY:
19948
AN XY:
74226
show subpopulations
African (AFR)
AF:
0.0791
AC:
3281
AN:
41472
American (AMR)
AF:
0.364
AC:
5554
AN:
15248
Ashkenazi Jewish (ASJ)
AF:
0.263
AC:
912
AN:
3468
East Asian (EAS)
AF:
0.145
AC:
747
AN:
5156
South Asian (SAS)
AF:
0.250
AC:
1198
AN:
4798
European-Finnish (FIN)
AF:
0.320
AC:
3371
AN:
10518
Middle Eastern (MID)
AF:
0.296
AC:
87
AN:
294
European-Non Finnish (NFE)
AF:
0.368
AC:
25020
AN:
67906
Other (OTH)
AF:
0.278
AC:
584
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1411
2823
4234
5646
7057
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
418
836
1254
1672
2090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.311
Hom.:
1012
Bravo
AF:
0.266
Asia WGS
AF:
0.181
AC:
630
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
2.5
DANN
Benign
0.60
PhyloP100
-0.063
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12923011; hg19: chr16-55525160; API